The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03343054
Brief Title: A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors

First Submitted : November 11, 2017
First Submitted that Met QC Criteria : November 11, 2017
First Posted : November 17, 2017

Results First Submitted : December 20, 2021
Results First Submitted that Met QC Criteria : December 20, 2021
Results First Posted : March 10, 2022

Last Update Submitted that Met QC Criteria : September 19, 2023
Last Update Posted : September 21, 2023